Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests ozanimod against standard drug for Steroid-Dependent UC

NCT ID NCT07271069

Recruiting now Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how well ozanimod works compared to azathioprine for people with steroid-dependent ulcerative colitis in Japan. Researchers will review medical records of 150 adults to see which drug helps patients stop steroids and stay symptom-free. The goal is to find a better treatment option for this chronic condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Ozanimod and azathioprine
What this could lead to
If ozanimod works better than azathioprine, it could offer a more effective way to control ulcerative colitis without long-term steroid use.
What could go wrong
This is an observational chart review, not a controlled trial, so results may be less reliable. The study is also limited to Japan, which may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ULCERATIVE COLITIS (UC)

Contacts and locations

Locations

  • Asahikawa Medical University

    RECRUITING

    Asahikawa, Hokkaido, 078-8510, Japan

  • Chiba University

    RECRUITING

    Chiba, Chiba, 263-8522, Japan

  • Ehime Prefectural Central Hospital

    NOT_YET_RECRUITING

    Matsuyama, Ehime, 790-0024, Japan

  • Fukuoka University Chikushi Hospital

    NOT_YET_RECRUITING

    Chikushino-shi, Fukuoka, 818-8502, Japan

  • Fukuoka University Chikushi Hospital

    RECRUITING

    Fukuoka, Fukuoka, 814-0180, Japan

  • Hamamatsu University School of Medicine

    RECRUITING

    Hamamatsu, Shizuoka, 431-3192, Japan

  • Hyogo Medical University

    RECRUITING

    Nishinomiya, Hyōgo, 663-8501, Japan

  • Kagawa Prefectural Central Hospital

    NOT_YET_RECRUITING

    Takamatsu, Kagawa-ken, 760-8557, Japan

  • Kansai Medical University

    RECRUITING

    Hirakata, Osaka, 573-1010, Japan

  • Kyorin University School of Medicine

    RECRUITING

    Mitaka-shi, Tokyo, 181-8611, Japan

  • Mebix. Inc.

    RECRUITING

    Minato-ku, Tokyo, 1070052, Japan

  • Saga University

    NOT_YET_RECRUITING

    Saga, Saga-ken, 840-8502, Japan

  • Saitama Medical Center, Saitama Medical University

    RECRUITING

    Hidaka-shi, Saitama, 350-1298, Japan

  • Sapporo Higashi Tokushukai Hospital

    RECRUITING

    Sapporo, Hokkaido, 065-0033, Japan

  • Sapporo Medical University School of Medicine

    RECRUITING

    Hokkaidō, Japan

  • Toho University Sakura Hospital

    RECRUITING

    Sakura, Chiba, 285-8741, Japan

  • Tottori University

    NOT_YET_RECRUITING

    Tottori-shi, Tottori, 680-8550, Japan

  • Tsujinaka Hospital Kashiwanoha

    RECRUITING

    Kashiwa-shi, Chiba, 277-0871, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.